S100A9 and myelodysplastic syndrome: In particular, the alarmin S100A9 and/or founder gene mutations lead to the generation of ROS and, consequently, to pyroptosis by activating the NLRP3 inflammasome and β-catenin, thereby ensuring the propagation of MDS clones.